CD8A and renal cell carcinoma: The enhancement in CD8+ TIL activation with CD28 costimulation was blocked following the addition of the glycolytic inhibitor 2-DG, indicating that the breakdown of glucose was necessary for downstream metabolic pathways serving the energetic needs of activated CD8+ RCC TILs.